Navigation Links
New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Date:11/7/2007

ORLANDO, Fla., Nov. 7 /PRNewswire-FirstCall/ -- A new analysis presented today from METEOR (Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40 mg slowed the progression of carotid intima-media thickness (CIMT) in four patient populations at varying levels of risk for cardiovascular disease. The sub- study was conducted in subjects defined by the Framingham risk assessment tool as having less than two or two or more risk factors (RF) and either thinner or thicker CIMT (<1.749 mm [median] vs. Greater Than or Equal To 1.749 mm). Results demonstrated that CRESTOR significantly slowed the progression of CIMT in all four subgroups (all p<0.02), compared to placebo treated subjects who all exhibited significantly higher progression rates. These data were presented at the American Heart Association Scientific Sessions in Orlando, Florida.

The new analysis showed that CRESTOR, when compared with placebo, slows progression of carotid atherosclerosis in subjects at relatively low risk for cardiovascular disease (<2RF + Thinner CIMT; 0.0007 mm/yr v. 0.0123 mm/yr with placebo and <2RF + Thicker CIMT; -0.0012 mm/yr v. 0.0116 mm/yr with placebo). Furthermore, those with more RFs and those with greater baseline thickness in the CRESTOR-treated group exhibited a greater trend toward regression or a greater negative slope (2+RF + Thinner CIMT; -0.0013 mm/yr v. 0.0144 mm/yr with placebo and 2+RF + Thicker CIMT; -0.0071 mm/yr v. 0.015 mm/yr with placebo).

"The METEOR trial continues to provide important information regarding the effects of CRESTOR on atherosclerotic progression in subjects with various degrees of risk based on conventional risk factors and carotid artery wall thickness," said John R. Crouse, III, M.D., lead investigator and Professor of Medicine at Wake Forest University School of Medicine, Winston-Salem, NC.

Atherosclerosis is a progressive disease that typically begins in ea
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Research (A*STAR) and Switzerland,s Cytos Biotechnology ... dosed in a Phase 1 clinical trial with their H1N1 ... particle (VLP) technology. In this first Phase 1 clinical trial, ... its potential to protect against H1N1 influenza infection will be ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
(Date:5/18/2013)... Wine World Accessories, a renowned online store ... attractive 25% discount on Franmara Dynamo Electric Wine ... purchase this electric corkscrew opener for $44.95 via Wine ... online store ensures delivery of their items within 1-2 ... , A spokesperson from the online store elaborates the ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Medical device company, ... for its much anticipated mobility aid with its namesake, the ... a hands-free crutch alternative that injured individuals can ... ankle, for example, can remain active and walk during a ... using its reservation system to ensure those who need the ...
(Date:5/18/2013)... 2013 Three new locations will be ... wellness centers and one therapeutic dispensary. Patient Appreciation Fair ... weekend of May 25th – May 27th, particularly honoring ... All events will take place from 11:00 ... Elements Therapeutic Dispensary , 10580 S. State Route 69, ...
(Date:5/17/2013)... inflict lasting damage to brain regions associated with fear ... stress disorder, or PTSD, have shown that these brain ... such as recalling a traumatic event or reacting to ... NYU School of Medicine have explored for the first ... with PTSD in the absence of external triggers. ...
Breaking Medicine News(10 mins):Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2
... of Facial Plastic Surgery, an innovative technique in African American rhinoplasty ... ... New York, NY (PRWEB) July 18, 2008 -- In a ... and Director of The Aesthetic Facial Surgery Institute of New ...
... intensive care can expect long-term quality of life at ... today in BioMed Central,s open access journal Critical ... allocation of resources to the treatment of heart attack ... other intensive care patient groups. , More than 600,000 ...
... for Healthcare Information Technology (CCHIT®) today announced that ... meets the Commission's ambulatory electronic health record (EHR) ... the CCHIT Certified seal, physicians and other providers ... product, allowing them to focus their evaluation on ...
... Universal,Health Services, Inc. (NYSE: UHS ) announced ... cash dividend of $0.08 per share on September 15,2008 ... Universal Health Services, Inc. is one of the ... and behavioral,health hospitals, and ambulatory centers nationwide and in ...
... reveal a lot about how they make decisions when feeling ... Associate Professor Uwe Dulleck, from the QUT Business Faculty, said ... it was, in fact, a natural reaction that had been ... the Australian arm of a study that was awarded an ...
... age 17 boosted odds for being heavy smoker , , THURSDAY, ... variations that affect their nicotine receptors seem to be at ... smoking before they turn 17, a new study says. ... young age are more likely to face severe nicotine dependence ...
Cached Medicine News:Health News:New Study Shows Facial Plastic Surgery Helps African American's Perserve Ethnicity 2Health News:New Study Shows Facial Plastic Surgery Helps African American's Perserve Ethnicity 3Health News:Heart attack not a death sentence 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 3Health News:Decisions under pressure: it's all in the heartbeat 2Health News:Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 2
... The mobile universal operating table for ... top allows for unlimited C-arm access. ... for both neurosurgical and cardiovascular procedures. ... for floor support can easily be ...
... the Cmax operating table that combines all ... table with the radiolucence and precise mobility ... most advanced, versatile surgical table on the ... support advancements in surgical procedures and imaging ...
... Table offers complete imaging access, with nearly ... and mobile imaging C-Arms can pan from ... reposition the patient. Anesthesiologists will appreciate this ... drive, quality construction, and ease of operation. ...
...
Medicine Products: